<DOC>
	<DOCNO>NCT02434549</DOCNO>
	<brief_summary>The purpose double-blinded , placebo-controlled study test treatment Botulinum toxin-A effective reduce chronic muscle-related pain adult spastic cerebral palsy .</brief_summary>
	<brief_title>Botulinum Toxin-A Treatment Chronic Muscle-Related Pain Adults With Spastic Cerebral Palsy : Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age ≥ 18 year . Spastic Cerebral Palsy . Chronic pain , relate spastic muscle . Chronic pain define : 1 ) Recurring regional pain least three month AND 2 ) Pain intensity average last 24 hour ≥3 Numerical Rating Scale . Signed Informed consent . Allergy/hypersensitivity Dysport® component . Pregnancy . Women breastfeed child . Treatment Botulinum toxinA within last five month . If dose change muscletone alter medication within two week Visit 1 . A clear degenerative cause behind pain elucidate clinical examination ( e.g . history osteoarthritis ) . Intellectual disability and/or communication impairment disable individual answering questionnaire give informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Placebo Controlled</keyword>
	<keyword>Double Blinded</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Adults</keyword>
	<keyword>Pain</keyword>
	<keyword>Spasticity</keyword>
	<keyword>Cerebral Palsy , Spastic</keyword>
	<keyword>Dysport</keyword>
</DOC>